Caplin Steriles gets FDA nod for Norepinephrine Bitartrate Injection
Caplin Steriles Limited, a subsidiary of Caplin Point Laboratories Limited has secured final approval from the United States Food and Drug Administration (FDA). The approval is for its Abbreviated New Drug Application (ANDA) Norepinephrine Bitartrate Injection USP, a generic equivalent of Hospira Inc’s LEVOPHED. Caplin’s Drug Targets $40 Million Market The approval comes as a […]